Results 221 to 230 of about 27,184 (256)

Bictegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly
  +8 more sources

Doxorubicin/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +1 more source

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Science, 2010
Anneke C Grobler, Cheryl Baxter, Leila E Mansoor   +2 more
exaly  

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2013
Michael Martin, Manoj Leethochawalit, Craig W Hendrix   +2 more
exaly  

Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

Science, 2017
Nichole R Klatt, Kenzie Birse, Alexander S Zevin   +2 more
exaly  

Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis

Gut, 2020
Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee   +2 more
exaly  

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

Science Translational Medicine, 2012
Peter L Anderson, David V Glidden, Albert Y Liu   +2 more
exaly  

Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis.

Journal of Antimicrobial Chemotherapy
I. Chivite, L. Berrocal, E. de Lazzari, Soodabeh Navadeh, Carla Lluis-Ganella, A. Inciarte, Lorena de la Mora, A. González-Cordón, M. Martínez-Rebollar, M. Laguno, B. Torres, J. L. Blanco, Esteban Martínez, Josep Mallolas, J. Ambrosioni   +14 more
semanticscholar   +1 more source

Gentamicin/tenofovir alafenamide

Reactions Weekly, 2020
openaire   +1 more source

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet Gastroenterology and Hepatology, 2016
Maria Buti, Henry Lik Yuen Chan, Wan-Long Chuang   +2 more
exaly